Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy

Psychiatry and Clinical Neurosciences

Volumn 58, Issue 6, 2004, Pages 630-635

  Sakamoto, Atsuhiro ^a   Ogawa, Ryo ^a   Suzuki, Hiroko ^a   Kimura, Mahito ^a   Okubo, Yoshiro ^a   Fujiya, Testuo ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Department of Neurology   (Japan)

Author keywords

Cognitive function; Electroconvulsive therapy; Hemodynamics; Landiolol

Indexed keywords

AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOMIPRAMINE; FLUVOXAMINE; LANDIOLOL; MIANSERIN; NORTRIPTYLINE; PROPOFOL; SUXAMETHONIUM;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; MAINTENANCE THERAPY; MALE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEIZURE; TACHYCARDIA;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANESTHESIA; ANESTHESIA RECOVERY PERIOD; CROSS-OVER STUDIES; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; PSYCHOMETRICS; SEIZURES; UREA;

EID: 11144245199     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2004.01322.x     Document Type: Article

References (25)

1. Abrams R. Electroconvulsive Therapy. Oxford University Press, New York, 2002.
2. Knos GB, Sung YF, Cooper RC, Stoudemire A. Electroconvulsive therapy - induced hemodynamic changes unmask unsuspected coronary artery disease. J. Clin. Anesth. 1990; 2: 37-41.
3. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth. Analg. 2002; 94: 1351-1364.
4. Weinger MB, Partridge BL, Hauger R, Mirow A. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics. Anesth. Analg. 1991; 73: 556-562.
5. Kovac AL, Goto H, Pardo MP, Arakawa K. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy. Can. J. Anaesth. 1991; 38: 204-209.
6. Avramov MN, Stool LA, White PF, Husain MM. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy. J. Clin. Anesth. 1998; 10: 394-400.
7. van den Broek WW, Leentjens AF, Mulder PG, Kusuma A, Bruijn JA. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study. Br. J. Anaesth. 1999; 83: 271-274.
8. Kirshenbaum JM, Kloner RA, Antman EM, Braunwald E. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. Circulation 1985; 72: 873-880.
9. Reilly CS, Wood M, Koshakji RP, Wood AJ. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade. Clin. Pharmacol. Ther. 1985; 38: 579-585.
10. Iguchi S, Iwamura H, Nishizaki M et al. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101. Chem. Pharm. Bull. (Tokyo) 1992; 40: 1462-1469.
11. Sugiyama A, Takahara A, Hashimoto K. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J. Cardiovasc. Pharmacol. 1999; 34: 70-77.
12. Kitamura A, Sakamoto A, Inoue T, Ogawa R. Efficacy of an ultrashort-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation. Eur. J. Clin. Pharmacol. 1997; 51: 467-471.
13. Hasuo H. Effect of ONO-1101, a novel short-acting β-blocker, on hemodynamic responses to isoflurane inhalation and tracheal intubation. J. Anesth. 1998; 12: 115-118.
14. Ahmet I, Fukushima N, Sawa Y et al. The effects of a new ultra-short-acting beta-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass. Surg. Today 1999; 29: 248-254.
15. Atarashi H, Kuruma A, Yashima M et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin. Pharmacol. Ther. 2000; 68: 143-150.
16. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can. J. Anaesth. 2001; 48: 985-989.
17. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189-198.
18. Ross CA, Peyser CE, Shapiro I, Folstein MF. Delirium: phenomenologic and etiologic subtypes. Int. Psychogeriatr. 1991; 3: 135-147.
19. Korttila K. Recovery from outpatient anaesthesia. Factors affecting outcome. Anaesthesia 1995; 50: 22-28.
20. Sakamoto A, Hoshino T, Suzuki N, Suzuki H, Kimura M, Ogawa R. Effects of propofol anesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry Clin. Neurosci. 1999; 53: 655-660.
21. Parnis SJ, van der Walt JH. A national survey of atropine use by Australian anaesthetists. Anaesth. Intensive Care 1994; 22: 61-65.
22. Kelway B, Simpson KH, Smith RJ, Halsall PJ. Effects of atropine and glycopyrrolate on cognitive function following anaesthesia and electroconvulsive therapy (ECT). Int. Clin. Psychopharmacol. 1986; 1: 296-302.
23. Royal College of Psychiatrists. The ECT Handbook: The second report of the Royal College of Psychiatrist's Special Committee on ECT CR39. Royal College of Psychiatrists, London, 1995.
24. Mayur PM, Shree RS, Gangadhar BN, Subbakrishna DK, Janakiramaiah N, Rao GS. Atropine premedication and the cardiovascular response to electroconvulsive therapy. Br. J. Anaesth. 1998; 81: 466-467.
25. McCall WV, Shelp FE, Weiner RD, Austin S, Harrill A. Effects of Labetalol on Hemodynamics and Seizure Duration During ECT. Convuls. Ther. 1991; 7: 5-14.